{
    "pmcid": "11055898",
    "qa_pairs": {
        "How can the insights from Rosetta modeling and MD simulations be applied according to the study?": [
            "To design nanobodies with optimized flexibility and binding properties",
            "To develop vaccines with longer shelf life",
            "To create diagnostic tools with higher sensitivity",
            "To engineer enzymes with enhanced catalytic activity"
        ],
        "What computational tool was used to refine and relax the structures of antibodies and their interactions with antigens in the study?": [
            "Rosetta",
            "AutoDock",
            "GROMACS",
            "PyMOL"
        ],
        "What did the molecular dynamics simulations reveal about the IgG3 and IgGh62 systems compared to IgG1?": [
            "They exhibited larger degrees of freedom and flexibility",
            "They showed reduced binding affinity",
            "They had increased thermal stability",
            "They demonstrated decreased solubility"
        ],
        "What was the primary focus of modifying the hinge region of antibodies in the study?": [
            "To improve flexibility and immune response mediation",
            "To increase antibody size and mass",
            "To enhance antibody solubility",
            "To decrease antibody degradation rate"
        ],
        "Which antibody subclass was engineered to combine the flexibility of IgG3 with the binding affinity of IgG1?": [
            "IgGh47",
            "IgGh62",
            "IgG2",
            "IgG4"
        ]
    }
}